Mondaq USA: Anti-trust/Competition Law
BakerHostetler
Clearly, "unfair methods of competition" include Sherman and Clayton Act violations, and some argue that Section 5 reaches beyond those statutes.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
This matter provides concrete and expanded guidance regarding conduct the FTC has deemed inconsistent with the investment-only exemption to the HSR Act's reporting requirements.
Jones Day
During the 2014 fiscal year, 1,663 transactions were reported to the federal antitrust agencies through the HSR premerger notification program.
Butler Snow LLP
Section 5 of the 1914 Federal Trade Commission Act declares that "unfair methods of competition in or affecting commerce" are unlawful.
Ropes & Gray LLP
Investment manager Third Point LLC and three of its affiliated funds have entered into a proposed settlement agreement with the federal antitrust authorities for violations of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, arising from improper reliance on the "investment-only" exemption.
Sheppard Mullin Richter & Hampton
Injury to competing retail fuel stations is non-actionable where market conditions demonstrate that an "incipient antitrust violation" is not imminent.
Jones Day
In 1914, Congress enacted Section 5, empowering the FTC to challenge "unfair methods of competition."
Morrison & Foerster LLP
The Federal Trade Commission's New Section 5 Statement Preserves the Agency's "Doctrinal Flexibility" but Fails to Provide Meaningful Concrete Guidance.
Patterson Belknap Webb & Tyler LLP
Last month, the Associated Presswas the first to report that the DOJ is investigating whether American Airlines, Delta Air Lines, Southwest Airlines, and United Airlines have engaged in collusion.
Sheppard Mullin Richter & Hampton
For many years, antitrust practitioners have struggled to understand exactly how the FTC will analyze and enforce Section 5's prohibition of "unfair methods of competition."
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
The Federal Trade Commission's ever-expanding list of enforcement actions to preserve competition for generic pharmaceuticals just grew in a new direction.
Barnes & Thornburg
Section 5 of the Federal Trade Commission Act declares "unfair methods of competition in or affecting commerce" as unlawful, 15 U.S.C. 45(a)(1).
Patterson Belknap Webb & Tyler LLP
This is our fourth post on the DOJ's expanding investigation into possible price fixing by generic drug manufacturers.
BakerHostetler
This week, FTC Chairwoman Edith Ramirez announced that the FTC had voted to issue a formal statement setting forth three "Enforcement Principles" governing its authority over "unfair methods of competition."
BakerHostetler
At least in the Second Circuit, this decision raises the stakes in future cases interpreting the scope of state-action immunity under the antitrust laws.
Patterson Belknap Webb & Tyler LLP
The Commissioners' vote on the new policy was 4-1.
Orrick
The Commission identified three core principles that will frame its decisions to challenge an act or practice as an unfair method of competition on a standalone Section 5 basis...
Morgan Lewis
The one-page statement, at the level of broad general principles, keeps with recent practice and does not signal any significant increase in enforcement under "unfair methods of competition" theories.
BakerHostetler
After years of academic debate and internal deliberation, the Federal Trade Commission today unveiled a "Statement of Enforcement Principles" that generally describes conduct prohibited by Section 5 of the FTC Act.
Womble Carlyle
In a short statement issued yesterday, the FTC issued guidance regarding how it will interpret Section 5 of the FTC Act.
Latest Video
Most Popular Recent Articles
McDermott Will & Emery
Bayer owns a patent on the active ingredient ciprofloxacin hydrochloride in the antibiotic Cipro®. It subsequently obtained approval from the U.S. Food and Drug Administration (FDA) to market the drug in the United States.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
The Federal Trade Commission's ever-expanding list of enforcement actions to preserve competition for generic pharmaceuticals just grew in a new direction.
McGuireWoods LLP
Continuing an EU-wide trend, yet another trade association has been fined in the UK for cartel activities.
Morrison & Foerster LLP
The Federal Trade Commission's New Section 5 Statement Preserves the Agency's "Doctrinal Flexibility" but Fails to Provide Meaningful Concrete Guidance.
Morrison & Foerster LLP
On July 16, the European Court of Justice issued its ruling in Huawei v. ZTE, which sets forth the factors to determine when enforcement of SEPs subject to commitments to license on FRAND terms may violate European competition law.
Patterson Belknap Webb & Tyler LLP
Last month, the Associated Presswas the first to report that the DOJ is investigating whether American Airlines, Delta Air Lines, Southwest Airlines, and United Airlines have engaged in collusion.
Womble Carlyle
Last month the Supreme Court declined to accept an appeal for two related antitrust cases involving an international price-fixing cartel.
Patterson Belknap Webb & Tyler LLP
We have been following developments in People of the State of New York v. Actavis, the New York Attorney General's "product hopping" suit against Actavis and its subsidiary, Forest Laboratories LLC.
Patterson Belknap Webb & Tyler LLP
This is our fourth post on the DOJ's expanding investigation into possible price fixing by generic drug manufacturers.
Schnader Harrison Segal & Lewis LLP
On June 26, 2015, the Third Circuit issued an opinion in King Drug Co. of Florence, Inc. v. Smithkline Beecham Corp., (Case No. 14-1243).
Article Search Using Filters
Related Topics
Mondaq Advice Center (MACs)
Popular Authors
Popular Contributors
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners